Highest EU court confirms pay for delay settlement agreements may be abusive and restrict competition by object or effect

On 30 January 2020, the Court of Justice of the EU (“CJEU”) confirmed that an agreement in settlement of a patent dispute in the pharmaceutical sector may constitute a restriction of competition by object or effect, as well as an abuse o...